Fig. 5.

Illustration of the method for the identification of infection-related infant outcomes in the BabyGel pilot trial. Infants participating in the study had the IMCI screening tool administered either at routine research visits or when their mothers brought them to participating hospitals or health centres. The group who screened positive were referred to the paediatric team at Mbale Hospital for clinical care, and along with those who died, composed the primary outcome for the study. Those who screened negative returned to the community. At the hospital, those who had screened positive had both a clinical and bacterial diagnosis performed; these were collected as secondary outcomes